Table 1 Patients’ demographics, central subfield thickness, best-corrected visual acuity and intraocular pressure at baseline and 12-week study visits
Patient | Information | Baseline | Follow-Up | Sex/age/eye |
|---|---|---|---|---|
1 | CST (μm) | 485 | 293 | M/65/R |
BCVA (LogMAR) | 20/80 | 20/20 | ||
IOP (mmHg) | 14 | 14 | ||
2 | CST | 358 | 346 | M/64/L |
BCVA | 20/60 | 20/30 | ||
IOP | 16 | 12 | ||
3 | CST | 463 | 321 | F/80/R |
BCVA | 20/60 | 20/40 | ||
IOP | 12 | 12 | ||
4 | CST | 406 | 334 | M/72/R |
BCVA | 20/400 | 20/160 | ||
IOP | 12 | 12 | ||
5 | CST | 342 | 291 | M/82/L |
BCVA | 20/70 | 20/50 | ||
IOP | 14 | 12 | ||
6 | CST | 613 | 409 | F/74/L |
BCVA | 20/400 | 20/160 | ||
IOP | 12 | 16 | ||
7 | CST | 389 | 257 | M/75/R |
BCVA | 20/100 | 20/60 | ||
IOP | 16 | 16 | ||
8 | CST | 337 | 286 | F/86/L |
BCVA | 20/100 | 20/80 | ||
IOP | 16 | 16 | ||
9 | CST | 528 | 407 | M/76/L |
BCVA | 20/320 | 20/250 | ||
IOP | 18 | 16 | ||
10 | CST | 364 | 324 | F/61/L |
BCVA | 20/100 | 20/70 | ||
IOP | 16 | 16 | ||
11 | CST | 783 | 543 | M/72/L |
BCVA | 20/70 | 20/30 | ||
IOP | 14 | 16 |